The Capacious and the Ambiguous in Biomolecular Engineering

Abstract

The significant clinical potential of biomedical endeavors provided by the functionings of biomolecular engineering can be illuminated especially vividly when utilizing various derivations of nucleic acid-based biological techniques, nanoparticles, and nanostructured dendrimers. Nucleic acids are capable of high-performance operation in genetic pathways and living systems at large in the form of tractable devices. Nanoparticles offer versatility in synthetic design. Dendrimers allow for biomaterial conjugations that can precisely transport drugs and kill targeted tumor cells. And especially when accompanied by specified conceptualizations of cell growth and drug delivery, these seismic areas of innovation demonstrate striking medical relevancy and immediacy. Imbued with an ethos of vertical integration, biotechnological interventions of the body will tend to establish bodies of medical knowledge at every scale and stage of diagnosis. The trajectory of biomolecular engineering will, however, need to address more social or humanistic complications related to the interstitial history of ethical transgression in the technological development of medicine.